BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11358146)

  • 1. Plastic microchip electrophoresis for genetic screening: the analysis of polymerase chain reactions products of fragile X (CGG)n alleles.
    Sung WC; Lee GB; Tzeng CC; Chen SH
    Electrophoresis; 2001 Apr; 22(6):1188-93. PubMed ID: 11358146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
    Sharma D; Gupta M; Thelma BK
    Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variation and intergenerational FMR1 CGG-repeat stability in 100 unrelated three-generation families from the normal population.
    Patsalis PC; Sismani C; Stylianou S; Ioannou P; Joseph G; Manoli P; Holden JJ; Hettinger JA
    Am J Med Genet; 1999 May; 84(3):217-20. PubMed ID: 10331595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of FMR-1 gene expression by RT-PCR].
    Zheng L; Fan Y; Huang T; Zhu N; Shen Y; Wu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Dec; 17(6):407-11. PubMed ID: 9208564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trinucleotide CGG repeat in the FMR1 gene in Chinese mentally retarded patients.
    Pang CP; Poon PM; Chen QL; Lai KY; Yin CH; Zhao Z; Zhong N; Lau CH; Lam ST; Wong CK; Brown WT
    Am J Med Genet; 1999 May; 84(3):179-83. PubMed ID: 10331586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mosaicism in a fragile X male including a de novo deletion in the FMR1 gene.
    Petek E; Kroisel PM; Schuster M; Zierler H; Wagner K
    Am J Med Genet; 1999 May; 84(3):229-32. PubMed ID: 10331598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis.
    Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K; Hasholt L; Vuust J
    Hum Genet; 1997 Oct; 100(5-6):564-8. PubMed ID: 9341871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of FMR1 (CGG)(n) alleles and DXS548-FRAXAC1 haplotypes in three European circumpolar populations: traces of genetic relationship with Asia.
    Larsen LA; Vuust J; Nystad M; Evseeva I; Van Ghelue M; Tranebjaerg L
    Eur J Hum Genet; 2001 Sep; 9(9):724-7. PubMed ID: 11571563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CGG repeat and the FMR1 gene.
    Stoyanova V; Oostra BA
    Methods Mol Biol; 2004; 277():173-84. PubMed ID: 15201456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkinsonism, FXTAS, and FMR1 premutations.
    Toft M; Aasly J; Bisceglio G; Adler CH; Uitti RJ; Krygowska-Wajs A; Lynch T; Wszolek ZK; Farrer MJ
    Mov Disord; 2005 Feb; 20(2):230-3. PubMed ID: 15390127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimization of polymerase chain reaction assay combined with capillary electrophoresis to detect the pre- and full mutation of FMR1 gene].
    Zhou Y; Sun W; Xiao B; Han X; Long F; Jiang WT; Ji X; Tao J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Aug; 28(4):401-5. PubMed ID: 21811979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot study for the neonatal screening of fragile X syndrome.
    Rifé M; Mallolas J; Badenas C; Tazón B; Miguélez MR; Pàmpols T; Sànchez A; Milà M
    Prenat Diagn; 2002 Jun; 22(6):459-62. PubMed ID: 12116303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive screening of fragile X syndrome A using urine and hair roots.
    Suwa K; Momoi MY
    Brain Dev; 2004 Sep; 26(6):380-3. PubMed ID: 15275700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-strand conformation polymorphism analysis in the FMR1 gene.
    Castellví-Bel S; Sánchez A; Badenas C; Mallolas J; Barceló A; Jiménez D; Villa M; Estivill X; Milà M
    Am J Med Genet; 1999 May; 84(3):262-5. PubMed ID: 10331603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of (CGG)n and FMR-1 associated microsatellite alleles in a normal Chilean population.
    Jara L; Aspillaga M; Avendaño I; Obreque V; Blanco R; Valenzuela CY
    Am J Med Genet; 1998 Jan; 75(3):277-82. PubMed ID: 9475597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.